Price and welfare effects of a pharmaceutical substitution reform
- 31 December 2010
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 29 (6) , 856-865
Abstract
No abstract availableKeywords
All Related Versions
This publication has 15 references indexed in Scilit:
- Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticalsHealth Policy, 2007
- Physicians' opinions and experiences of the Pharmaceutical Benefits ReformScandinavian Journal of Public Health, 2006
- Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in IndiaAmerican Economic Review, 2006
- Impact of Generic Substitution on Pharmaceutical Prices and Expenditures in OECD CountriesJournal of Pharmaceutical Finance, Economics & Policy, 2006
- What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in SwedenPharmacoepidemiology and Drug Safety, 2004
- Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expendituresJournal of Health Economics, 2000
- Generic Entry and the Pricing of PharmaceuticalsJournal of Economics & Management Strategy, 1997
- Estimates of the demand for ethical pharmaceutical drugs across countries and timeApplied Economics, 1994
- Pricing, Patent Loss and the Market for PharmaceuticalsSouthern Economic Journal, 1992
- Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical IndustryBrookings Papers on Economic Activity. Microeconomics, 1991